From METTL3 PROTACs to pyroptosis-coupled design: a medicinal chemistry agenda for next-generation targeted degraders

Medicinal Chemistry Research 2026

View at publisher
Authors: Mulavagili Vijayasimha
DOI: 10.1007/s00044-026-03535-4
Cited by: 0
References: 10

Fields of Study & Subjects

Protein Degradation and Inhibitors Ubiquitin and proteasome pathways Chemical Synthesis and Analysis

Publication details

Journal / source
Medicinal Chemistry Research
Volume
35
Issue
5
Pages
867–870
Publication date
6 March 2026
Language
EN